Clinical Trials Directory

Trials / Conditions / Lung Fibrosis

Lung Fibrosis

12 registered clinical trials studyying Lung Fibrosis — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingImpact of Airway Mucus Plugs on Secondary Pulmonary Fibrosis in COPD Patients: A Single-Center Case-Control St
NCT07236541
Ming Zhong—
RecruitingHome-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
NCT06751069
Mayo ClinicN/A
Active Not RecruitingPulmonary Outcomes on Patients With Lung Fibrosis
NCT07088185
South Valley UniversityN/A
RecruitingRole of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases
NCT06189820
Erasme University HospitalPhase 2
UnknownDigital App for Telerehabilitation in Respiratory Diseases
NCT05572346
MedicAir Healthcare S.r.l.—
UnknownStudy to Assess Efficacy and Safety of Treamid for Patients With Reduced Exercise Tolerance After COVID-19
NCT05516550
PHARMENTERPRISES LLCPhase 2 / Phase 3
RecruitingPulmonary Fibrosis Foundation Community Registry
NCT05382572
Pulmonary Fibrosis Foundation—
CompletedAnti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis
NCT05648734
Mansoura University—
RecruitingImmune Modulation by Exosomes in COVID-19
NCT05191381
University of Ulm—
UnknownLow-field Magnetic Resonance Imaging of Pediatric COVID-19
NCT04990531
University of Erlangen-Nürnberg Medical SchoolN/A
CompletedA Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis
NCT04274257
Tokyo UniversityPhase 2 / Phase 3
CompletedCyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease
NCT01570764
Assistance Publique - Hôpitaux de ParisPhase 3